2024 Jama cardiology - JAMA Cardiology. Key Points. Question Is COVID-19 vaccination linked to the occurrence of myocarditis? Findings In this study of 7 patients with acute myocarditis, 4 occurred within 5 days of COVID-19 vaccination between February 1 and April 30, 2021. All 4 ...

 
 Bonow RO , Carabello BA , Chatterjee K , et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. . Jama cardiology

Disclaimer: Dr Sabatine is Deputy Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Beltrán-Sánchez H , Harhay MO , Harhay MM , McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.Our acceptance rate of 7% for original science manuscripts is on par with the other major journals in our field. After only 3 years of publishing, JAMA Cardiology’s impact factor was 11.9 in 2019 (which is reported for 2018). As anticipated, the continuous flow of manuscripts has increased the workload of our very busy editors, but we relish ... Douglas PS , Garcia MJ , Haines DE , et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of ... JAMA Cardiology. Key Points. Question How is kidney transplant associated with cardiovascular functional reserve? Findings In this cohort study of 166 patients with stage 5 chronic kidney disease and 87 patients with hypertension only to assess change to cardiovascular functional reserve after improving the uremic milieu through a kidney ...Key Points. Question Can mendelian randomization identify associations between circulating cardiovascular disease–related proteins and hypertensive disorders of pregnancy (HDPs)?. Findings In this genetic association study including data from 21 758 participants for cardiovascular disease–related proteins, 393 238 female individuals for gestational …Under the premise of sex-specific physiology, we calculated between-sex differences (women minus men) in the change of BP values from baseline, and these data demonstrate faster rates of increase in women than men for all BP measures, particularly for systolic BP and pulse pressure (PP). Fitted lines denote mean sex differences in incremental BP … JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Cardiology—The Year in Review, 2023. Robert O. Bonow, MD, MS JAMA Cardiol March 13, 2024. Original Investigation. Quantitative Coronary Angiography vs ... JAMA Cardiology. Myocarditis is a significant cause of sudden cardiac death in competitive athletes and can occur with normal ventricular function. 1 Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), ...ObjectiveTo determine the association between ambulatory hemodynamic monitoring and rates of HF hospitalization at 12 months in clinical practice. Design, Setting, and ParticipantsThis matched cohort study of Medicare beneficiaries used claims data collected between June 1, 2014, and March 31, 2016. Medicare patients who received implants of a ...Key Points. Question Is patient sex associated with differences in clinical outcomes of pulsed field ablation (PFA) for the treatment of patients with atrial fibrillation (AF)?. Findings In this large cohort study using a patient-level registry including 1568 consecutive patients who underwent PFA for paroxysmal or persistent AF, there was no significant difference …Key Points. Question How much would the highly atherogenic lipoprotein(a) have to be lowered to decrease the coronary heart disease outcomes in the same range as observed for a lowering of low-density lipoprotein cholesterol by 38.67 mg/dL?. Findings In this mendelian randomization analysis, it was estimated that lipoprotein(a) would have to …Improvement in cardiovascular outcomes has slowed, and the obesity epidemic that contributed to cardiovascular disease continues. Given the current uncertain state of knowledge, neither patients nor physicians can be confident that omega-3 fatty acids have any health benefits, yet in 2019 the global market for omega-3 fatty acids reached $4.1 ...In this issue of JAMA Cardiology, Jaeger and colleagues 1 report a secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) study evaluating the association of long-term intensive blood pressure (BP) treatment with cardiovascular and all-cause mortality. Sadly, the robust reduction in mortality seen in the intensive treatment group …JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA … JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Genetically elevated lipoprotein (a) and increased risk of myocardial infarction. JAMA. 2009;301 (22):2331-2339. PubMed Google Scholar. Clarke R, Peden JF, Hopewell JC, et al; PROCARDIS Consortium. Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N Engl J Med. 2009;361 (26):2518-2528. Das SR , Everett BM , Birtcher KK , et al. 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology task force on expert consensus decision pathways. JAMA Cardiology. Key Points. Question Is a ticagrelor-based or prasugrel hydrochloride–based strategy superior for patients with acute coronary syndrome treated with percutaneous coronary intervention? Findings In this prespecified subgroup analysis of a randomized clinical trial, among ...JAMA Cardiology. Key Points. Question Can readily available electrocardiogram (ECG) data be used to train a high-performing convolutional neural network (CNN) across a large range of 12-lead ECG diagnoses when compared with clinical standards of care?Mar 6, 2024 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Cardiology. Full Text. Leaving the broken system the way it is, that’s not a solution. 1. Barack Obama. It must be recognized that our current health care delivery system has failed to adequately treat 2 of our nation’s top cardiovascular risk factors: high blood pressure (BP) and hyperlipidemia.Dr Yancy is Deputy Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Virani SS , Alonso A , Benjamin EJ , et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. ...JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts …Improvement in cardiovascular outcomes has slowed, and the obesity epidemic that contributed to cardiovascular disease continues. Given the current uncertain state of knowledge, neither patients nor physicians can be confident that omega-3 fatty acids have any health benefits, yet in 2019 the global market for omega-3 fatty acids reached $4.1 ...Disclaimer: Dr Sabatine is Deputy Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Beltrán-Sánchez H , Harhay MO , Harhay MM , McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.JAMA Cardiology. Key Points. Question What is the effect of treatment with mavacamten on Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy? Findings In this phase 3 randomized clinical trial of 81 patients, mavacamten significantly improved Valsalva left ventricular outflow tract obstruction compared with placebo and was ...Disclaimer: Dr Thomas is the Assistant Editor for Statistics of JAMA Cardiology, Dr Hernandez is an Associate Editor for JAMA Cardiology, and Dr Fonarow is the Associate Editor of Health Care Quality and Guidelines for JAMA Cardiology, but they were not involved in any of the decisions regarding review of the manuscript or its acceptance.JAMA Cardiology. Medical News & Perspectives. Highlights From the American Heart Association’s Scientific Sessions—ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, Aspirin and Dementia, and More. Jennifer Abbasi. … In this issue of JAMA Cardiology, Lindner and colleagues 4 report on 39 autopsy cases of patients with COVID-19 in whom pneumonia was the clinical cause of death in 35 of 39 (89.7%). While histopathologic evaluation did not meet criteria seen in acute myocarditis, there was evidence of virus present in the heart in 24 of 39 patients (61.5% ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Cardiology. Comment & Response. To DOAC or Not to DOAC for Left Ventricular Thrombi—What Is the Dose? Arun Manmadhan, MD; Jeffrey S. Berger, MD, MS; Tania Ahuja, PharmD. JAMA Cardiology. Key Points.JAMA Cardiology. Key Points. Question What is the effect of treatment with mavacamten on Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy? Findings In this phase 3 randomized clinical trial of 81 patients, mavacamten significantly improved Valsalva left ventricular outflow tract obstruction compared with placebo and was ...Key Points. Question Can a deep learning model using routinely acquired outpatient 12-lead electrocardiograms (ECGs) in sinus rhythm predict the presence of atrial fibrillation (AF) within 31 days across diverse populations?. Findings In this prognostic study, a model trained on data from 2 large Veterans Affairs (VA) hospital networks predicted AF with …A, Probability of the primary composite end point, with extrapolated mean event-free survival time at age 65 years of 6.2 years for placebo and 8.3 years for dapagliflozin (difference, 2.1 years; 95% CI, 0.8-3.3 years; P = .002).B, Probability of death from any cause, with mean extrapolated life expectancy of 9.1 years for placebo and 10.8 years for dapagliflozin (difference, 1.7 years; 95% …Key Points. Question In patients diagnosed with atrial fibrillation before 66 years of age, what is the prevalence of disease-associated variants in susceptibility genes for inherited cardiomyopathy and arrhythmia syndromes?. Findings In this cohort study, among 1293 participants who underwent whole genome sequencing, disease-associated rare …JAMA Cardiology. Myocarditis is a significant cause of sudden cardiac death in competitive athletes and can occur with normal ventricular function. 1 Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Cardiology. Explore the latest in cardiology, including treatment of acute coronary syndromes, dyslipidemia, heart failure, rhythm disorders, and more. Add to My Interests. JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) MeaningRestrictions on trans-fatty acid consumption are associated with a decrease in hospitalization for cardiovascular events. ImportanceTrans-fatty acids (TFAs) have deleterious cardiovascular effects. Restrictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011.Our acceptance rate of 7% for original science manuscripts is on par with the other major journals in our field. After only 3 years of publishing, JAMA Cardiology’s impact factor was 11.9 in 2019 (which is reported for 2018). As anticipated, the continuous flow of manuscripts has increased the workload of our very busy editors, but we relish ...JAMA Cardiology, Chicago, Illinois. 57,031 likes · 154 talking about this · 9 were here. JAMA Cardiology is a member of the JAMA Network, a consortium of...Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345 (20):1435-1443. PubMed Google Scholar Crossref. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators. Use of a continuous-flow device in …Disclaimer: Dr Fonarow is Associate Section Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. Meeting Presentation: This paper was presented at the American College of Cardiology 23rd Annual Scientific Session and Expo; March 4, 2023; New Orleans, Louisiana.JAMA Cardiology. Myocarditis is a significant cause of sudden cardiac death in competitive athletes and can occur with normal ventricular function. 1 Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), ... Key Points. Question What are the trends in heart failure (HF)–related mortality in young adults?. Findings In this cohort study, 61 729 HF-related deaths were identified in young adults between 1999 and 2019, and the overall age-adjusted mortality rate per 100 000 persons increased from 2.36 in 1999 to 3.16 in 2019. JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Disclaimer: Dr Thomas is the Assistant Editor for Statistics of JAMA Cardiology, Dr Hernandez is an Associate Editor for JAMA Cardiology, and Dr Fonarow is the Associate Editor of Health Care Quality and Guidelines for JAMA Cardiology, but they were not involved in any of the decisions regarding review of the manuscript or its acceptance.Our acceptance rate of 7% for original science manuscripts is on par with the other major journals in our field. After only 3 years of publishing, JAMA Cardiology’s impact factor was 11.9 in 2019 (which is reported for 2018). As anticipated, the continuous flow of manuscripts has increased the workload of our very busy editors, but we relish ... Douglas PS , Garcia MJ , Haines DE , et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of ... In this issue of JAMA Cardiology, Lindner and colleagues 4 report on 39 autopsy cases of patients with COVID-19 in whom pneumonia was the clinical cause of death in 35 of 39 (89.7%). While histopathologic evaluation did not meet criteria seen in acute myocarditis, there was evidence of virus present in the heart in 24 of 39 patients (61.5% ... Jul 1, 2018 · Genetically elevated lipoprotein (a) and increased risk of myocardial infarction. JAMA. 2009;301 (22):2331-2339. PubMed Google Scholar. Clarke R, Peden JF, Hopewell JC, et al; PROCARDIS Consortium. Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N Engl J Med. 2009;361 (26):2518-2528. Training and credentialing guidelines are inconsistent across medical fields, with cardiology requiring 150 studies performed and 300 interpreted before independent practice 23 while the American College of Emergency Physicians allows as few as 25 cardiac studies for competence. 24 An unintended consequence of varying training …Jul 1, 2020 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Cardiology. Key Points. Question What is the risk of myocarditis after mRNA-based COVID-19 vaccination in the US? Findings In this descriptive study of 1626 cases of myocarditis in a national passive reporting system, the crude reporting rates within 7 days after vaccination exceeded the expected rates across multiple age and sex strata ...Disclaimer: Dr Sabatine is Deputy Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Beltrán-Sánchez H , Harhay MO , Harhay MM , McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.Importance Primary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on risk stratification. Genome-wide polygenic risk scores (PRSs) are proposed to improve ASCVD risk estimation. Objective To determine whether genome-wide PRSs for coronary artery disease (CAD) and acute ischemic stroke improve ASCVD risk estimation with traditional clinical risk …JAMA Cardiology. Key Points. Question Is the burden of atrial fibrillation associated with the risk of ischemic stroke and other thromboembolism in paroxysmal atrial fibrillation? Findings In a cohort study of 1965 adults with paroxysmal atrial fibrillation, a greater ...Importance Limited evidence suggests exercise reduces blood pressure (BP) in individuals with resistant hypertension, a clinical population with low responsiveness to drug therapy.. Objective To determine whether an aerobic exercise training intervention reduces ambulatory BP among patients with resistant hypertension.. Design, Settings, and …JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA … Key Points. Question What are the trends in heart failure (HF)–related mortality in young adults?. Findings In this cohort study, 61 729 HF-related deaths were identified in young adults between 1999 and 2019, and the overall age-adjusted mortality rate per 100 000 persons increased from 2.36 in 1999 to 3.16 in 2019. After 8 years of publishing, JAMA Cardiology ’s journal impact factor was 24.0 in 2023 (reported for the year 2022). Our weekly content of original … JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Cardiology. Key Points. Question What is the optimal target for reduction of systolic blood pressure among patients with hypertension? Findings In this systematic review and network meta-analysis of 42 trials, including 144 220 patients, linear ...Cardiology. Explore the latest in cardiology, including treatment of acute coronary syndromes, dyslipidemia, heart failure, rhythm disorders, and more. Add to My Interests.In this issue of JAMA Cardiology, Liu et al 2 provide important new data from 2 secondary prevention samples (UK Biobank, N = 14 478; Emory Cardiovascular Biobank, N = 5467). The prevalence of very high HDL-C (>80 mg/dL) was low in both samples (<2%) and comprised a higher proportion of women and those reporting frequent alcohol use; low ...Key Points. Question Is the clinical benefit of low-density lipoprotein cholesterol (LDL-C) lowering preserved in patient populations starting with LDL-C levels averaging 1.8 mmol/L (70 mg/dL) or less, and is LDL-C lowering safe in such patients?. Findings In this meta-analysis, for statins and nonstatins, the risk of major vascular …Importance Computed tomography–derived fractional flow reserve (FFR-CT) is a novel, noninvasive test for myocardial ischemia. Clinicians using FFR-CT must be able to interpret individual FFR-CT results to determine subsequent patient care. Objective To provide clinicians a means of interpreting individual FFR-CT results with respect to the range of …Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345 (20):1435-1443. PubMed Google Scholar Crossref. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators. Use of a continuous-flow device in …JAMA Cardiology. Key Points. Question How many clinically significant variants for familial hypercholesterolemia would be missed by limited-variant screening conducted on microarrays? Findings In this cross-sectional review of comprehensive genetic test results for individuals with indications for familial hypercholesterolemia, a limited ...JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959)This analysis of pooled data from 2 randomized clinical trials evaluates the 5-year incidence, clinical outcomes, and predictors of hemodynamic structural valve deterioration in patients undergoing self-expanding transcatheter aortic valve implantation or surgery.JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & …JAMA Cardiology. Full Text. Abstract Importance Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 people around the world of every race and ethnicity.In this issue of JAMA Cardiology, Jaeger and colleagues 1 report a secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) study evaluating the association of long-term intensive blood pressure (BP) treatment with cardiovascular and all-cause mortality. Sadly, the robust reduction in mortality seen in the intensive treatment group …Key Points. Question Does tafamidis, 80 mg, affect cardiac function in patients with transthyretin amyloid cardiomyopathy?. Findings In this post hoc analysis of the randomized Tafamidis in Transthyretin Cardiomyopathy Clinical Trial including 441 patients, over 30 months, there was less pronounced worsening of left ventricular (LV) stroke volume, LV …Key Points. Question Is there an association between normal systolic blood pressure values as currently defined and atherosclerotic cardiovascular disease among persons without traditional cardiovascular disease risk factors?. Findings In this cohort study including 1457 participants without atherosclerotic cardiovascular disease, beginning with a systolic …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959)JAMA Cardiology. Key Points. Question Is a ticagrelor-based or prasugrel hydrochloride–based strategy superior for patients with acute coronary syndrome treated with percutaneous coronary intervention? Findings In this prespecified subgroup analysis of a randomized clinical trial, among ...Rodeohouston, Marlborough pizza, Baldwin county arrests, Arc beauty, Rudy's breakfast tacos, Mail.yahoo inbox, De online, Skully's music, Tony's pizza willimantic, Cabela's scarborough maine, Perry ymca, Nearest driving range, Bobcat football, Village of bethalto

JAMA Cardiology. Coronavirus disease 2019 (COVID-19) is associated with significant mortality and morbidity, including adverse cardiovascular sequelae. 1 As public health policy begins to guide the resumption of recreational and competitive sport, clinicians are charged with determining when competitive athletes and highly active individuals .... Life way christian

jama cardiologyz's bubble tea

JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Jan 14, 2021 · Thirty of 789 athletes (3.8%) had abnormal cardiac screening test results necessitating additional evaluation and downstream testing; 5 athletes (0.6%) were detected to have findings raising concern for COVID-19–associated inflammatory heart disease that resulted in restriction from sport participation per American Heart Association (AHA)/American College of Cardiology (ACC) guidelines. 10 ... JAMA Cardiology. Key Points. Question Which factors are associated with the outcome of patients with RYR2 catecholaminergic polymorphic ventricular tachycardia during β-blocker treatment? Findings In this cohort study including 216 patients with RYR2 catecholaminergic polymorphic ventricular tachycardia, symptoms ...In this Viewpoint, JAMA Cardiology editors review the journal's more inportant articles advancing the scientific understanding of COVID-19 and the heart in the first 6 months of the pandemic, including evidence of …JAMA Cardiology. Key Points. Question Can readily available electrocardiogram (ECG) data be used to train a high-performing convolutional neural network (CNN) across a large range of 12-lead ECG diagnoses when compared with clinical standards of care?Information, Instructions for Authors, and additional resources for authors interested in submitting manuscripts to the JAMA Network journals—JAMA, JAMA Network Open, and the 11 JAMA specialty journals—are available for each journal below.Selected manuscripts submitted to JAMA that are not accepted may be referred to one of the specialty journals with the author's …In the Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2 (STOPDAPT-2) trial, 1161 patients with acute coronary syndrome (ACS) were enrolled and randomized at 75 centers in Japan from December 2015 to December 2017, while in the STOPDAPT-2 ACS trial, 3008 patients with ACS were … Bonow RO , Carabello BA , Chatterjee K , et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. Disclaimer: Dr Fonarow is Associate Section Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. Meeting Presentation: This paper was presented at the American College of Cardiology 23rd Annual Scientific Session and Expo; March 4, 2023; New Orleans, Louisiana.JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & …This secondary analysis of the Systolic Blood Pressure Intervention Trial evaluates the long-term effects of randomization to intensive treatment with the incidence of cardiovascular and all-cause …Key Points. Question Does an entirely remote hypertension and hypercholesterolemia program implemented across a large diverse health network help ensure equal access to care?. Findings In this cohort study including 10 803 patients with blood pressure and/or cholesterol levels above guideline-recommended targets, remote medication titration management was significantly … Heidenreich PA , Bozkurt B , Aguilar D , et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Key Points. Question Does tafamidis, 80 mg, affect cardiac function in patients with transthyretin amyloid cardiomyopathy?. Findings In this post hoc analysis of the randomized Tafamidis in Transthyretin Cardiomyopathy Clinical Trial including 441 patients, over 30 months, there was less pronounced worsening of left ventricular (LV) stroke volume, LV …Disclaimer: Dr Hernandez is associate editor, Dr Yancy is deputy editor, and Dr Fonarow is associate editor of the Health Care Quality and Guidelines section for JAMA Cardiology, but they were not involved in any of the decisions regarding the review and acceptance of the manuscript.Key Points. Question What is the diagnostic and prognostic value of stress cardiovascular magnetic resonance imaging (CMR) for the evaluation of stable chest pain?. Findings In this systematic review and meta-analysis pooling 74 470 patients with stable chest pain over 381 357 person-years of follow-up, stress CMR yielded high diagnostic accuracy and …Our acceptance rate of 7% for original science manuscripts is on par with the other major journals in our field. After only 3 years of publishing, JAMA Cardiology’s impact factor was 11.9 in 2019 (which is reported for 2018). As anticipated, the continuous flow of manuscripts has increased the workload of our very busy editors, but we relish ...This analysis of pooled data from 2 randomized clinical trials evaluates the 5-year incidence, clinical outcomes, and predictors of hemodynamic structural valve deterioration in patients undergoing self-expanding transcatheter aortic valve implantation or surgery. JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) This secondary analysis of the Systolic Blood Pressure Intervention Trial evaluates the long-term effects of randomization to intensive treatment with the incidence of cardiovascular and all-cause …JAMA Cardiology. Key Points. Question What is the risk of aortic dissection (AD) and all-cause death for nonsyndromic patients with unrepaired ascending thoracic aortic aneurysm (TAA), overall and by …In the Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2 (STOPDAPT-2) trial, 1161 patients with acute coronary syndrome (ACS) were enrolled and randomized at 75 centers in Japan from December 2015 to December 2017, while in the STOPDAPT-2 ACS trial, 3008 patients with ACS were …Genetically elevated lipoprotein (a) and increased risk of myocardial infarction. JAMA. 2009;301 (22):2331-2339. PubMed Google Scholar. Clarke R, Peden JF, Hopewell JC, et al; PROCARDIS Consortium. Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N Engl J Med. 2009;361 (26):2518-2528.JAMA Cardiology. Country. United States. Universities and research institutions in United States. Media Ranking in United States. Subject Area and Category. …Key Points. Question What are the trends in heart failure (HF)–related mortality in young adults?. Findings In this cohort study, 61 729 HF-related deaths were identified in young adults between 1999 and 2019, and the …A, Overall survival of patients with DNMT3A or TET2 mutations with a VAF greater than 0.005 to 0.01; a VAF of at least 0.01 to 0.02; a VAF of at least 0.02; and non-CHIP patients reveals dose-response of clone size and clinical outcome; B, Event-free survival free of death or rehospitalization for heart failure with DNMT3A or TET2 mutations at various … JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Key Points. Question Do contemporary machine learning methods improve prediction of in-hospital death after hospitalization for acute myocardial infarction (AMI)?. Findings In this cohort study of 755 402 patients with AMI in a nationwide registry, machine learning models that used the same data inputs as logistic regression were not associated with …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts …JAMA Cardiology. Key Points. Question Can coronary artery calcium score identify individuals likely to derive net benefit from aspirin therapy for primary prevention of atherosclerotic cardiovascular disease? Findings In this cohort study, using participants from the Dallas Heart Study cohort who were free from atherosclerotic cardiovascular ...Disclaimer: Dr Sabatine is Deputy Editor of JAMA Cardiology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Beltrán-Sánchez H , Harhay MO , Harhay MM , McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.JAMA Cardiology. Key Points. Question Is a ticagrelor-based or prasugrel hydrochloride–based strategy superior for patients with acute coronary syndrome treated with percutaneous coronary intervention? Findings In this prespecified subgroup analysis of a randomized clinical trial, among ...Key Points. Question Are initial and serial increases in high-sensitivity C-reactive protein levels after acute coronary syndrome in medically optimized patients associated with increased risk of a major cardiac event, cardiovascular death, and all-cause death?. Findings In this secondary analysis of the VISTA-16 randomized clinical trial that …JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & … JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) This analysis of pooled data from 2 randomized clinical trials evaluates the 5-year incidence, clinical outcomes, and predictors of hemodynamic structural valve deterioration in patients undergoing self-expanding transcatheter aortic valve implantation or surgery.JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Key Points. Question What is the association of pulmonary hypertension with clinical outcomes in patients undergoing transcatheter mitral valve repair?. Findings In this cohort study of 4071 patients in the Society of Thoracic Surgery/American College of Cardiology Transcatheter Valve Therapy registry, pulmonary hypertension was common and …JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology will focus on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic ...Key Points. Question What are the characteristics and outcomes of patients with heart transplant who are infected with coronavirus disease 2019 (COVID-19)?. Findings In this case series of 28 patients who had received heart transplant in a large academic center, the case fatality rate among patients infected with COVID-19 was 25%. . Cardiovascular comorbidities …The JAMA Cardiology Patient Page is a public service of JAMA Cardiology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Cardiology suggests that you …Importance Increasing cardiology workforce diversity will expand the talent of the applicant pool and may reduce health care disparities.. Objective To assess US cardiology physician workforce demographics by sex and race/ethnicity in the context of the US population and the available pipelines of trainees.. Design, Setting, and Participants This cross-sectional study used data … This cohort study performs a post hoc analysis of data for US and Australian participants in the Aspirin in Reducing Events in the Elderly (ASPREE) clinical trial to determine the association between level of high-density lipoprotein cholesterol and increased fracture risk in healthy older adults. Bonow RO , Carabello BA , Chatterjee K , et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & … Bonow RO , Carabello BA , Chatterjee K , et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. JAMA Cardiology. Key Points. Question When does the clinical benefit of dapagliflozin emerge in patients with heart failure with reduced ejection fraction, and what is the magnitude as a function of proximity to prior heart failure hospitalization?JAMA Cardiology. Editor's Comment. A Brief Window to Rethink Emergency Care. Melinda B. Buntin, PhD. JAMA Health Forum. We are in the midst of the coronavirus disease 2019 (COVID-19) pandemic and, as many clinicians across the globe, we are seeing firsthand the pain and death caused by COVID-19.PMID: 32730619. PMCID: PMC7385689. DOI: 10.1001/jamacardio.2020.3557. Abstract. Importance: Coronavirus disease 2019 …All results were obtained through meta-analysis among 3 cohorts. Model 1 was adjusted by age and sex at the time of blood sample collection; model 2 was adjusted by age, sex, body mass index (BMI), smoking status, and physical activity at the time of blood sample collection; and model 3 was adjusted by age, sex, BMI, smoking status, …Jan 1, 2022 · This post hoc analysis of data from the Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) randomized clinical trial assesses the safety and efficacy of omecamtiv mecarbil for the treatment of patients with severe heart failure. In this issue of JAMA Cardiology, Lindner and colleagues 4 report on 39 autopsy cases of patients with COVID-19 in whom pneumonia was the clinical cause of death in 35 of 39 (89.7%). While histopathologic evaluation did not meet criteria seen in acute myocarditis, there was evidence of virus present in the heart in 24 of 39 patients (61.5% ... Importance Primary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on risk stratification. Genome-wide polygenic risk scores (PRSs) are proposed to improve ASCVD risk estimation. Objective To determine whether genome-wide PRSs for coronary artery disease (CAD) and acute ischemic stroke improve ASCVD risk estimation with traditional clinical risk …A, Percentage of patients who achieved low-density lipoprotein cholesterol (LDL-C) levels less than 70 mg/dL and less than 55 mg/dL (to convert to millimoles per liter, multiply by 0.0259) at baseline and 2 years of follow-up in the Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) registry.JAMA Cardiology. Key Points. Question What is the optimal target for reduction of systolic blood pressure among patients with hypertension? Findings In this systematic review and network meta-analysis of 42 trials, including 144 220 patients, linear ...JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary …Importance In the last decade, immune checkpoint inhibitors (ICIs) have been approved for the treatment of many cancer types. Immune checkpoint inhibitor–associated myocarditis has emerged as a significant and potentially fatal adverse effect. Recognizing, diagnosing, and treating ICI-associated myocarditis poses new challenges for the practicing clinician.MeaningRestrictions on trans-fatty acid consumption are associated with a decrease in hospitalization for cardiovascular events. ImportanceTrans-fatty acids (TFAs) have deleterious cardiovascular effects. Restrictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011. This analysis of data from the 2016 Global Burden of Disease Study examines the national and province-level mortality, prevalence, and disability-adjusted life-years associated with cardiovascular disease in China from 1990 to 2016. JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Cardiology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the ...McMurray JJ , Adamopoulos S , Anker SD , et al; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology developed in collaboration with the Heart Failure Association (HFA) of …JAMA Cardiology. Key Points. Question How is kidney transplant associated with cardiovascular functional reserve? Findings In this cohort study of 166 patients with stage 5 chronic kidney disease and 87 patients with hypertension only to assess change to cardiovascular functional reserve after improving the uremic milieu through a kidney ...JAMA Cardiology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & …Importance Cardiovascular disease is a leading cause of morbidity in cancer survivors, which makes strategies aimed at mitigating cardiovascular risk a subject of major contemporary importance.. Objective To assess whether a center-based cardiac rehabilitation (CBCR) framework compared with usual care encompassing community-based exercise training … JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Cardiology. Myocarditis is a significant cause of sudden cardiac death in competitive athletes and can occur with normal ventricular function. 1 Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), ...Additionally, information on cardiac arrest causative mechanism (presumed cardiac, respiratory, drug overdose, and other mechanism) and as to whether bystander cardiopulmonary resuscitation (CPR) or defibrillation … A, Composite outcome, B, all-cause mortality, and C, major cardiovascular disease (CVD) adjusted for age, sex, urban or rural residence, country income level, education level, household wealth index, smoking status, physical activity, depression, baseline chronic diseases, physical impairments, and a random intercept for clustering of centers. The 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America Guideline for the Management of Heart Failure recommends the use of cardiac biomarkers, namely natriuretic peptides and cardiac troponins, for HF classification. 4 Within this framework, ambulatory patients with elevated levels of NT …Our acceptance rate of 7% for original science manuscripts is on par with the other major journals in our field. After only 3 years of publishing, JAMA Cardiology’s impact factor was 11.9 in 2019 (which is reported for 2018). As anticipated, the continuous flow of manuscripts has increased the workload of our very busy editors, but we relish ...Jul 1, 2018 · Genetically elevated lipoprotein (a) and increased risk of myocardial infarction. JAMA. 2009;301 (22):2331-2339. PubMed Google Scholar. Clarke R, Peden JF, Hopewell JC, et al; PROCARDIS Consortium. Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N Engl J Med. 2009;361 (26):2518-2528. We would like to show you a description here but the site won’t allow us.. The nail spa, Corner bar, Fish dope, City of mount dora, Spinx car wash, Reno orthopaedic clinic, Iwcc iowa, Who buys antiques near me, Launch asheville, House hasson, Juan rivera doctor, Desert dwellers, Fried crabs near me, Clopay garage doors, Coblestone auto spa, Green hyundai, Danny's cycles, Bj reece.